Reviewed clinical summary · Source-linked · Educational use only

Can Moxibustion and Low-Dose Tadalafil Improve Diabetes-Related ED?

Clinical Bottom Line

Summary: In male patients with diabetes mellitus-induced erectile dysfunction (DMED), combination therapy with moxibustion plus low-dose tadalafil (5 mg daily) demonstrated significantly improved erectile function (IIEF scores), penile blood flow parameters, and TCM syndrome scores compared to moxibustion alone and low-dose tadalafil…

Summary:

In male patients with diabetes mellitus-induced erectile dysfunction (DMED), combination therapy with moxibustion plus low-dose tadalafil (5 mg daily) demonstrated significantly improved erectile function (IIEF scores), penile blood flow parameters, and TCM syndrome scores compared to moxibustion alone and low-dose tadalafil alone in a three-arm trial design, with only minor transient side effects reported.

PICO Description
Population Male patients with diabetes mellitus-induced erectile dysfunction (DMED).
Intervention Combination therapy with moxibustion plus low-dose tadalafil (5 mg daily).
Comparison Moxibustion alone and low-dose tadalafil alone (three-arm trial design).
Outcome Combination therapy significantly improved IIEF scores and penile blood flow compared to either treatment alone. Minor transient side effects only.
RCT Zhonghua Nan Ke Xue · 2025

Moxibustion + low-dose tadalafil for diabetic ED

RCT · type 2 diabetes-induced ED · 4 weeks

Trial design
Men with DMED (Qi-def/stasis) Enrolled & assessed RANDOMISED 1:1:1 Mox + tadalafil Moxibustion + TAD 5 mg n = 30 Tadalafil alone Tadalafil 5 mg daily n = 30 Total effectiveness rate at 4 weeks
Proportion reaching endpoint
RR 1.50 % effective 90% Mox + tadalafil 60% Tadalafil alone ARR+30 pts vs TAD
Effectiveness
90.0%
Mox+TAD
Effectiveness
60.0%
TAD alone
Effectiveness
46.7%
Mox alone
IIEF-5 / EHS
Up
Most in Mox+TAD
⬡ Bottom Line

Adding moxibustion to low-dose tadalafil raised the total effectiveness rate to 90% versus 60% with tadalafil alone, with greater gains in IIEF-5, EHS and penile peak systolic velocity.

Clinical Context

Erectile dysfunction affects 35-75% of men with diabetes. Moxibustion combined with low-dose PDE5 inhibitor therapy may offer synergistic benefits through different mechanisms.

Clinical Pearls

1. Synergistic Mechanism: Tadalafil enhances NO-mediated vasodilation while moxibustion may improve blood circulation through different pathways.

2. Low-Dose Daily Tadalafil Context: Daily 5 mg tadalafil provides continuous PDE5 inhibition with endothelial rehabilitative effects.

3. Three-Arm Design Clarifies Contributions: The study demonstrates benefits exceed either monotherapy.

4. Penile Hemodynamic Improvements: Objective improvements in penile blood flow strengthen the evidence.

Practical Application

For diabetic men with ED who have partial response to PDE5 inhibitors alone, adjunctive moxibustion therapy may provide additional benefit. Continue optimizing diabetes management.

Study Limitations

Single-center study with limited sample size. Blinding is impossible for moxibustion. Long-term durability wasn’t assessed.

Bottom Line

Moxibustion combined with low-dose tadalafil significantly improves erectile function in diabetic men compared to either treatment alone.

Source: Liu T, et al. “Moxibustion Combined with Low-Dose Tadalafil for Diabetes Mellitus-Induced Erectile Dysfunction: A Prospective, Single-Center, Three-Arm Randomized Controlled Trial.” Read article

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.